Close

Ratings by JPMorgan (Eric Joseph)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/17/2024 Nurix NRIX Maintain Overweight
(N/A)
 
 
  Details
5/21/2024 PTC Therapeutics PTCT Maintain Overweight
(N/A)
 
 
  Details
5/13/2024 Prime Medicine PRME Maintain Overweight
(N/A)
 
 
  Details
5/10/2024 Novavax NVAX Upgrade Neutral
(Underweight)
4.47
(13.14)
193.96% Details
5/3/2024 Vir Biotechnology VIR Maintain Neutral
(N/A)
 
 
  Details
5/3/2024 Biomea Fusion Inc. BMEA Maintain Neutral
(N/A)
 
 
  Details
4/10/2024 Nurix NRIX Maintain Overweight
(N/A)
 
 
  Details
4/2/2024 Biomea Fusion Inc. BMEA Downgrade Neutral
(Overweight)
14.95
(4.89)
-67.29% Details
2/27/2024 Verve Therapeutics VERV Maintain Neutral
(N/A)
 
 
  Details
2/27/2024 Beam Therapeutics Inc BEAM Maintain Overweight
(N/A)
 
 
  Details
2/23/2024 Vir Biotechnology VIR Maintain Neutral
(N/A)
 
 
  Details
2/23/2024 Kymera Therapeutics KYMR Maintain Overweight
(N/A)
 
 
  Details
2/16/2024 Nurix NRIX Maintain Overweight
(N/A)
 
 
  Details
2/8/2024 Enanta Pharmaceuticals ENTA Maintain Underweight
(N/A)
 
 
  Details
2/5/2024 TG Therapeutics TGTX Maintain Overweight
(N/A)
 
 
  Details
2/5/2024 PTC Therapeutics PTCT Maintain Overweight
(N/A)
 
 
  Details
1/29/2024 Vir Biotechnology VIR Downgrade Neutral
(Overweight)
9.70
(8.97)
-7.53% Details
1/29/2024 Beam Therapeutics Inc BEAM Upgrade Overweight
(Neutral)
24.92
(23.34)
-6.34% Details
1/29/2024 C4 Therapeutics CCCC Upgrade Neutral
(Underweight)
5.69
(4.01)
-29.53% Details
1/4/2024 Kymera Therapeutics KYMR Upgrade Overweight
(Neutral)
22.90
(30.98)
35.28% Details
12/6/2023 IGM Biosciences IGMS Maintain Neutral
(N/A)
 
 
  Details
11/10/2023 Pliant Therapeutics PLRX Maintain Overweight
(N/A)
 
 
  Details
11/10/2023 HilleVax, Inc. HLVX Maintain Overweight
(N/A)
 
 
  Details
11/9/2023 Monte Rosa Therapeutics GLUE Maintain Overweight
(N/A)
 
 
  Details
11/6/2023 Prime Medicine PRME Maintain Overweight
(N/A)
 
 
  Details
10/19/2023 PTC Therapeutics PTCT Maintain Overweight
(N/A)
 
 
  Details
10/17/2023 Rocket Pharmaceuticals RCKT Maintain Neutral
(N/A)
 
 
  Details
10/10/2023 Akero Therapeutics AKRO Maintain Overweight
(N/A)
 
 
  Details
10/9/2023 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
9/15/2023 PTC Therapeutics PTCT Maintain Overweight
(N/A)
 
 
  Details
8/28/2023 Lyell Immunopharma LYEL Downgrade Neutral
(Overweight)
2.23
(2.10)
-5.83% Details
8/28/2023 Century Therapeutics IPSC Downgrade Neutral
(Overweight)
2.40
(3.14)
30.83% Details
8/10/2023 Pliant Therapeutics PLRX Maintain Overweight
(N/A)
 
 
  Details
8/10/2023 Atea Pharmaceuticals AVIR Downgrade Underweight
(Neutral)
3.41
(3.55)
4.11% Details
8/9/2023 Terns Pharmaceuticals TERN Maintain Neutral
(N/A)
 
 
  Details
8/9/2023 Enanta Pharmaceuticals ENTA Downgrade Underweight
(N/A)
18.52
(11.60)
-37.37% Details
8/9/2023 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
8/7/2023 TG Therapeutics TGTX Maintain Overweight
(N/A)
 
 
  Details
8/3/2023 Kymera Therapeutics KYMR Maintain Neutral
(N/A)
 
 
  Details
7/21/2023 Vir Biotechnology VIR Maintain Overweight
(N/A)
 
 
  Details
6/26/2023 Biomea Fusion Inc. BMEA Maintain Overweight
(N/A)
 
 
  Details
6/20/2023 Biomea Fusion Inc. BMEA Maintain Overweight
(N/A)
 
 
  Details
5/25/2023 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
5/16/2023 IGM Biosciences IGMS Maintain Neutral
(N/A)
 
 
  Details
5/16/2023 HilleVax, Inc. HLVX Maintain Overweight
(N/A)
 
 
  Details
5/16/2023 Terns Pharmaceuticals TERN Maintain Neutral
(N/A)
 
 
  Details
5/12/2023 Monte Rosa Therapeutics GLUE Maintain Overweight
(N/A)
 
 
  Details
5/9/2023 Revolution RVMD Maintain Overweight
(N/A)
 
 
  Details
5/8/2023 PTC Therapeutics PTCT Maintain Overweight
(N/A)
 
 
  Details
5/5/2023 Autolus Therapeutics plc AUTL Maintain Neutral
(N/A)
 
 
  Details
5/2/2023 TG Therapeutics TGTX Maintain Overweight
(N/A)
 
 
  Details
4/28/2023 bluebird bio BLUE New Coverage Overweight
(N/A)
3.68
(0.88)
-76.09% Details
4/19/2023 Relay Therapeutics RLAY Maintain Overweight
(N/A)
 
 
  Details
4/17/2023 Rocket Pharmaceuticals RCKT Maintain Neutral
(N/A)
 
 
  Details
4/5/2023 Relay Therapeutics RLAY Maintain Overweight
(N/A)
 
 
  Details
4/3/2023 IGM Biosciences IGMS Maintain Neutral
(N/A)
 
 
  Details
3/29/2023 Terns Pharmaceuticals TERN Maintain Neutral
(N/A)
 
 
  Details
3/28/2023 Biomea Fusion Inc. BMEA Maintain Overweight
(N/A)
 
 
  Details
3/17/2023 Monte Rosa Therapeutics GLUE Maintain
(Overweight)
 
 
  Details
3/15/2023 Biomea Fusion Inc. BMEA Maintain Overweight
(N/A)
 
 
  Details
3/7/2023 Autolus Therapeutics plc AUTL Maintain Neutral
(N/A)
 
 
  Details
3/6/2023 Vir Biotechnology VIR Upgrade Overweight
(Neutral)
22.61
(8.97)
-60.33% Details
3/1/2023 Beam Therapeutics Inc BEAM Maintain Neutral
(N/A)
 
 
  Details
3/1/2023 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
2/28/2023 Revolution RVMD Upgrade Overweight
(Neutral)
24.33
(37.25)
53.1% Details
2/24/2023 C4 Therapeutics CCCC Downgrade Underweight
(Neutral)
5.92
(4.01)
-32.26% Details
2/22/2023 PTC Therapeutics PTCT Maintain Overweight
(N/A)
 
 
  Details
2/13/2023 Nurix NRIX Maintain Overweight
(N/A)
 
 
  Details
2/9/2023 Ironwood Pharmaceuticals IRWD Maintain Neutral
(N/A)
 
 
  Details
2/8/2023 Enanta Pharmaceuticals ENTA Maintain Neutral
(N/A)
 
 
  Details
1/10/2023 Rocket Pharmaceuticals RCKT Maintain Neutral
(N/A)
 
 
  Details
12/16/2022 Ironwood Pharmaceuticals IRWD Maintain Neutral
(N/A)
 
 
  Details
12/14/2022 Mirati Therapeutics MRTX Maintain Neutral
(N/A)
 
 
  Details
12/8/2022 Mirati Therapeutics MRTX Downgrade Neutral
(Overweight)
71.52
(58.70)
-17.93% Details
12/7/2022 Pliant Therapeutics PLRX New Coverage Overweight
(N/A)
17.00
(10.85)
-36.18% Details
12/6/2022 Mirati Therapeutics MRTX Maintain Overweight
(N/A)
 
 
  Details
11/29/2022 Surrozen Inc. SRZN Downgrade Underweight
(Neutral)
0.82
(11.00)
1241.46% Details
11/14/2022 Prime Medicine PRME New Coverage Overweight
(N/A)
20.57
(6.38)
-68.98% Details
11/4/2022 Kymera Therapeutics KYMR Maintain Neutral
(N/A)
 
 
  Details
11/4/2022 Karyopharm Therapeutics KPTI Maintain Neutral
(N/A)
 
 
  Details
11/4/2022 C4 Therapeutics CCCC Downgrade Neutral
(Overweight)
9.70
(4.01)
-58.66% Details
10/28/2022 PTC Therapeutics PTCT Maintain Overweight
(N/A)
 
 
  Details
10/17/2022 Livent Corp. LTHM New Coverage Neutral
(N/A)
28.51
(16.51)
-42.09% Details
10/17/2022 Surrozen Inc. SRZN New Coverage Neutral
(N/A)
2.40
(11.00)
358.33% Details
10/17/2022 IGM Biosciences IGMS New Coverage Neutral
(N/A)
21.83
(7.25)
-66.79% Details
9/26/2022 Mirati Therapeutics MRTX Maintain Overweight
(N/A)
 
 
  Details
9/22/2022 Novavax NVAX Downgrade Underweight
(Neutral)
27.46
(4.47)
-83.72% Details
8/4/2022 Karyopharm Therapeutics KPTI Maintain Neutral
(N/A)
 
 
  Details
8/2/2022 Mirati Therapeutics MRTX New Coverage Overweight
(N/A)
64.40
(58.70)
-8.85% Details
8/2/2022 Lyell Immunopharma LYEL New Coverage Overweight
(N/A)
5.57
(2.10)
-62.3% Details
8/2/2022 Biomea Fusion Inc. BMEA New Coverage Overweight
(N/A)
10.60
(4.89)
-53.87% Details
6/21/2022 PTC Therapeutics PTCT Maintain Overweight
(N/A)
 
 
  Details
5/24/2022 HilleVax, Inc. HLVX New Coverage Overweight
(N/A)
10.17
(14.47)
42.28% Details
5/19/2022 Rocket Pharmaceuticals RCKT Maintain Overweight
(N/A)
 
 
  Details
5/5/2022 Ironwood Pharmaceuticals IRWD Maintain Neutral
(N/A)
 
 
  Details
4/18/2022 TG Therapeutics TGTX Maintain Overweight
(N/A)
 
 
  Details
3/23/2022 Enanta Pharmaceuticals ENTA Maintain Neutral
(N/A)
 
 
  Details
3/23/2022 Terns Pharmaceuticals TERN Downgrade Neutral
(Overweight)
3.06
(7.28)
137.91% Details
3/15/2022 Verve Therapeutics VERV Maintain Neutral
(N/A)
 
 
  Details
3/14/2022 Aligos Therapeutics Inc. ALGS Maintain Neutral
(N/A)
 
 
  Details
3/10/2022 Kymera Therapeutics KYMR New Coverage Neutral
(N/A)
36.26
(30.98)
-14.56% Details
3/10/2022 C4 Therapeutics CCCC New Coverage Overweight
(N/A)
21.00
(4.01)
-80.9% Details
3/1/2022 Revolution RVMD Maintain Neutral
(N/A)
 
 
  Details
3/1/2022 Novavax NVAX Maintain Neutral
(N/A)
 
 
  Details
3/1/2022 Biomea Fusion Inc. BMEA Maintain Overweight
(N/A)
 
 
  Details
2/28/2022 Beam Therapeutics Inc BEAM Maintain Neutral
(N/A)
 
 
  Details
2/9/2022 Karyopharm Therapeutics KPTI Upgrade Neutral
(Underweight)
10.24
(0.95)
-90.72% Details
1/7/2022 Aligos Therapeutics Inc. ALGS Downgrade Neutral
(Overweight)
10.61
(0.44)
-95.85% Details
11/10/2021 Achilles Therapeutics ACHL Maintain Underweight
(N/A)
 
 
  Details
10/27/2021 Myovant Sciences Ltd. MYOV Maintain Overweight
(N/A)
 
 
  Details
10/20/2021 Atea Pharmaceuticals AVIR Downgrade Neutral
(Overweight)
40.60
(3.55)
-91.26% Details
10/8/2021 Relay Therapeutics RLAY Upgrade Overweight
(Neutral)
26.00
(7.43)
-71.42% Details
10/8/2021 Omeros Corp. OMER Downgrade Underweight
(Neutral)
7.21
(4.07)
-43.55% Details
9/27/2021 Omeros Corp. OMER New Coverage Neutral
(N/A)
15.95
(7.21)
-54.8% Details
9/9/2021 Humanigen HGEN Downgrade Underweight
(Neutral)
15.11
(0.04)
-99.74% Details
8/18/2021 Terns Pharmaceuticals TERN Maintain Overweight
(N/A)
 
 
  Details
8/17/2021 Freeline FRLN Downgrade Neutral
(Overweight)
3.35
(6.48)
93.43% Details
8/13/2021 Relay Therapeutics RLAY Maintain Neutral
(N/A)
 
 
  Details
8/10/2021 Achilles Therapeutics ACHL Maintain Underweight
(N/A)
 
 
  Details
8/6/2021 Karyopharm Therapeutics KPTI Downgrade Underweight
(Overweight)
7.82
(0.95)
-87.85% Details
7/29/2021 Myovant Sciences Ltd. MYOV Maintain Overweight
(N/A)
 
 
  Details
7/21/2021 Enanta Pharmaceuticals ENTA Maintain Neutral
(N/A)
 
 
  Details
7/21/2021 Myovant Sciences Ltd. MYOV Maintain Overweight
(N/A)
 
 
  Details
7/19/2021 Monte Rosa Therapeutics GLUE New Coverage Overweight
(N/A)
19.12
(3.80)
-80.13% Details
7/13/2021 Century Therapeutics IPSC New Coverage Overweight
(N/A)
27.61
(3.14)
-88.63% Details
7/12/2021 Verve Therapeutics VERV New Coverage Neutral
(N/A)
46.25
(5.19)
-88.78% Details
5/20/2021 Black Diamond Therapeutics BDTX Maintain Overweight
(N/A)
 
 
  Details
5/14/2021 Beam Inc BEAM Maintain Neutral
(N/A)
 
 
  Details
5/12/2021 Novavax NVAX Downgrade Neutral
(Overweight)
138.18
(13.14)
-90.49% Details
5/11/2021 Biomea Fusion Inc. BMEA New Coverage Overweight
(N/A)
16.94
(4.89)
-71.13% Details
5/10/2021 Black Diamond Therapeutics BDTX Maintain Overweight
(N/A)
 
 
  Details
3/25/2021 Black Diamond Therapeutics BDTX Maintain Overweight
(N/A)
 
 
  Details
3/4/2021 Five Prime Therapeutics FPRX Maintain Neutral
(N/A)
 
 
  Details
3/2/2021 Terns Pharmaceuticals TERN New Coverage Overweight
(N/A)
24.64
(7.28)
-70.45% Details
2/25/2021 Rocket Pharmaceuticals RCKT Maintain Overweight
(N/A)
 
 
  Details
2/23/2021 Humanigen HGEN New Coverage Neutral
(N/A)
23.83
(0.04)
-99.83% Details
1/29/2021 Novavax NVAX Maintain Overweight
(N/A)
 
 
  Details
1/29/2021 Akebia Therapeutics AKBA Downgrade Underweight
(Neutral)
3.49
(1.04)
-70.2% Details
1/29/2021 Beam Inc BEAM Downgrade Neutral
(Overweight)
92.01
(23.34)
-74.63% Details
1/29/2021 Enanta Pharmaceuticals ENTA Upgrade Neutral
(Underweight)
48.96
(11.60)
-76.31% Details
1/29/2021 AUTL AUTL Downgrade Neutral
(Overweight)
8.10
(4.13)
-49.01% Details
12/21/2020 Myovant Sciences Ltd. MYOV Maintain Overweight
(N/A)
 
 
  Details
11/23/2020 Rocket Pharmaceuticals RCKT Maintain Overweight
(N/A)
 
 
  Details
11/16/2020 Urovant Ltd. UROV Downgrade Neutral
(Overweight)
8.28
(16.24)
96.14% Details
11/11/2020 Five Prime Therapeutics FPRX Upgrade Neutral
(Underweight)
5.49
(38.00)
592.17% Details
11/9/2020 ObsEva OBSV Downgrade Underweight
(Neutral)
1.97
(0.10)
-94.92% Details
10/15/2020 Nurix NRIX Maintain Overweight
(N/A)
 
 
  Details
10/7/2020 PTC Therapeutics PTCT Upgrade Overweight
(Neutral)
49.97
(35.50)
-28.96% Details
9/3/2020 Akebia Therapeutics AKBA Downgrade Neutral
(Overweight)
10.00
(1.04)
-89.6% Details
9/1/2020 Freeline FRLN New Coverage Overweight
(N/A)
16.15
(6.48)
-59.88% Details
9/1/2020 TG Therapeutics TGTX New Coverage Overweight
(N/A)
24.50
(16.70)
-31.84% Details
8/19/2020 Momenta Pharmaceuticals MNTA Downgrade Neutral
(Overweight)
30.81
(52.48)
70.33% Details
8/17/2020 Nurix NRIX New Coverage Overweight
(N/A)
23.88
(16.30)
-31.74% Details
8/10/2020 Relay Therapeutics RLAY New Coverage Neutral
(N/A)
41.02
(26.00)
-36.62% Details
8/5/2020 Novavax NVAX Upgrade Overweight
(Neutral)
155.87
(138.18)
-11.35% Details
7/31/2020 AUTL AUTL New Coverage Overweight
(N/A)
13.20
(4.13)
-68.71% Details
7/7/2020 ObsEva OBSV Downgrade Neutral
(Overweight)
6.15
(0.10)
-98.37% Details
7/2/2020 Rocket Pharmaceuticals RCKT New Coverage Overweight
(N/A)
20.93
(20.74)
-0.91% Details
6/5/2020 Novavax NVAX Upgrade Neutral
(Underweight)
44.66
(13.14)
-70.58% Details
3/9/2020 Revolution RVMD New Coverage Neutral
(N/A)
32.98
(37.25)
12.95% Details
3/5/2020 ObsEva OBSV Maintain Overweight
(N/A)
 
 
  Details
3/2/2020 Beam Inc BEAM New Coverage Overweight
(N/A)
22.93
(23.34)
1.79% Details
2/28/2020 Five Prime Therapeutics FPRX Downgrade Underweight
(Neutral)
4.83
(38.00)
686.75% Details
2/24/2020 Black Diamond Therapeutics BDTX New Coverage Overweight
(N/A)
37.03
(5.38)
-85.47% Details
1/15/2020 Momenta Pharmaceuticals MNTA Upgrade Overweight
(Neutral)
20.50
(30.81)
50.29% Details
9/26/2019 Enanta Pharmaceuticals ENTA Downgrade Underweight
(Neutral)
71.82
(11.60)
-83.85% Details
7/23/2019 Karyopharm Therapeutics KPTI Upgrade Overweight
(Neutral)
8.30
(0.95)
-88.55% Details
6/14/2019 Melinta Therapeutics Inc. MLNT Downgrade Underweight
(Neutral)
1.82
(0.50)
-72.53% Details
5/2/2019 Akebia Therapeutics AKBA New Coverage Overweight
(N/A)
6.04
(10.00)
65.56% Details
4/22/2019 Precision BioSciences Inc. DTIL New Coverage Overweight
(N/A)
12.18
(10.51)
-13.71% Details
3/5/2019 ObsEva OBSV Maintain Overweight
(N/A)
 
 
  Details
3/1/2019 Karyopharm Therapeutics KPTI Downgrade Neutral
(Overweight)
4.40
(8.30)
88.64% Details
2/28/2019 Novavax NVAX Downgrade Underweight
(Overweight)
2.13
(13.14)
516.9% Details
1/4/2019 Momenta Pharmaceuticals MNTA Downgrade Neutral
(Overweight)
10.66
(20.50)
92.31% Details
11/14/2018 Sangamo BioSciences SGMO Downgrade Neutral
(Overweight)
10.00
(0.42)
-95.8% Details
11/7/2018 Ironwood Pharmaceuticals IRWD Downgrade Underweight
(Neutral)
14.13
(12.72)
-9.98% Details
10/3/2018 PTC Therapeutics PTCT Maintain Neutral
(N/A)
 
 
  Details
9/21/2018 Novavax NVAX Upgrade Overweight
(Underweight)
1.47
(2.13)
44.9% Details
9/13/2018 ObsEva OBSV New Coverage Overweight
(N/A)
14.49
(0.10)
-99.31% Details
9/13/2018 Myovant Sciences Ltd. MYOV New Coverage Overweight
(N/A)
23.12
(26.98)
16.7% Details